ARCHIVES

Cooperative Group Chairman Unhappy Over Exclusion From Funding at Recommended Levels

This article is from The Cancer Letter archive.

Vol. 09 No. 46 | December 2, 1983

Download PDF Visit The Full Archive

Related Articles

Adjuvant Radiation Treatment Shows Improved Survival In Elderly, Early-Stage Patients

November 30, 2012

Deals & Collaborations: UAB To Evaluate Firm’s Prostate Cancer Treatment

June 1, 2001

ODAC Prefers Three-Hour Taxol Infusion. Says Data Dosage Still Uncertain

October 1, 1993

NCI Plans Preclinical Studies Of Endoxifen, A Tamoxifen Metabolite.

August 7, 2009

ODAC Supports Approval For Taxotere In Breast Cancer, Hycamtin In Lung Cancer

June 5, 1998

In Brief: New Contract To Speed Drug Development Planned; Groups To Get $5.6 Million Extra

February 27, 1976